Showing results (111-120 of 332) with videos related to

Sort By:
Pageof 34
Oncotarget|October 17, 2018
Clofarabine-based reduced intensity conditioning regimen with peripheral blood stem cell graft and post-transplant cyclophosphamide in adults with myeloid malignanciesPatrice Chevallier, Pierre Peterlin, Alice Garnier, et al.
Leukemia & Lymphoma|June 9, 2020
Ponatinib-based therapy in adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the real-life OPAL studySuzanne Tavitian, Madalina Uzunov, Emilie Bérard, et al.
Oncotarget|February 10, 2018
Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remissionFrancesco Saraceni, Myriam Labopin, Rose-Marie Hamladji, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2016
Late Complications and Quality of Life after Reduced-Intensity Conditioning Allogeneic Stem Cell TransplantationAline Clavert, Zinaida Peric, Eolia Brissot, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2009
Infectious complications after unrelated umbilical cord blood transplantation in adult patients with hematologic malignanciesXavier Cahu, Fanny Rialland, Cyrille Touzeau, et al.
Bone Marrow Transplantation|April 18, 2018
Refined graft-versus-host disease/relapse-free survival in transplant from HLA-identical related or unrelated donors in acute myeloid leukemiaGiorgia Battipaglia, Annalisa Ruggeri, Myriam Labopin, et al.
Oncoimmunology|June 28, 2021
Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell responseDhon Roméo Makanga, Maxime Jullien, Gaëlle David, et al.
American Journal of Hematology|June 13, 2020
Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission: On behalf of the acute leukemia working party of the European society for blood and marrow transplantationArnon Nagler, Myriam Labopin, Jonathan Canaani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2010
Impact of cyclosporine-A concentration on the incidence of severe acute graft-versus-host disease after allogeneic stem cell transplantationFlorent Malard, Richard M Szydlo, Eolia Brissot, et al.
Haematologica|March 15, 2015
The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationMarie Thérèse Rubio, Myriam Labopin, Didier Blaise, et al.
Pageof 34